Cargando…

Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility

The germline TP53 p.R337H mutation is reported as the most common germline TP53 variant. It exists at a remarkably high frequency in the population of southeast Brazil as founder mutation in two distinct haplotypes with the most frequent co-segregating with the p.E134∗ variant of the XAF1 tumor supp...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Emilia M., Fridman, Cintia, Figueiredo, Bonald C., Salvador, Hector, Teixeira, Manuel R., Pinto, Carla, Pinheiro, Manuela, Kratz, Christian P., Lavarino, Cinzia, Legal, Edith A.M. F., Le, Anh, Kelly, Gregory, Koeppe, Erika, Stoffel, Elena M., Breen, Kelsey, Hahner, Stefanie, Heinze, Britta, Techavichit, Piti, Krause, Amanda, Ogata, Tsutomu, Fujisawa, Yasuko, Walsh, Michael F., Rana, Huma Q., Maxwell, Kara N., Garber, Judy E., Rodriguez-Galindo, Carlos, Ribeiro, Raul C., Zambetti, Gerard P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597792/
https://www.ncbi.nlm.nih.gov/pubmed/37794678
http://dx.doi.org/10.1016/j.xhgg.2023.100244
_version_ 1785125421674659840
author Pinto, Emilia M.
Fridman, Cintia
Figueiredo, Bonald C.
Salvador, Hector
Teixeira, Manuel R.
Pinto, Carla
Pinheiro, Manuela
Kratz, Christian P.
Lavarino, Cinzia
Legal, Edith A.M. F.
Le, Anh
Kelly, Gregory
Koeppe, Erika
Stoffel, Elena M.
Breen, Kelsey
Hahner, Stefanie
Heinze, Britta
Techavichit, Piti
Krause, Amanda
Ogata, Tsutomu
Fujisawa, Yasuko
Walsh, Michael F.
Rana, Huma Q.
Maxwell, Kara N.
Garber, Judy E.
Rodriguez-Galindo, Carlos
Ribeiro, Raul C.
Zambetti, Gerard P.
author_facet Pinto, Emilia M.
Fridman, Cintia
Figueiredo, Bonald C.
Salvador, Hector
Teixeira, Manuel R.
Pinto, Carla
Pinheiro, Manuela
Kratz, Christian P.
Lavarino, Cinzia
Legal, Edith A.M. F.
Le, Anh
Kelly, Gregory
Koeppe, Erika
Stoffel, Elena M.
Breen, Kelsey
Hahner, Stefanie
Heinze, Britta
Techavichit, Piti
Krause, Amanda
Ogata, Tsutomu
Fujisawa, Yasuko
Walsh, Michael F.
Rana, Huma Q.
Maxwell, Kara N.
Garber, Judy E.
Rodriguez-Galindo, Carlos
Ribeiro, Raul C.
Zambetti, Gerard P.
author_sort Pinto, Emilia M.
collection PubMed
description The germline TP53 p.R337H mutation is reported as the most common germline TP53 variant. It exists at a remarkably high frequency in the population of southeast Brazil as founder mutation in two distinct haplotypes with the most frequent co-segregating with the p.E134∗ variant of the XAF1 tumor suppressor and an increased cancer risk. Founder mutations demonstrate linkage disequilibrium with neighboring genetic polymorphic markers that can be used to identify the founder variant in different geographic regions and diverse populations. We report here a shared haplotype among Brazilian, Portuguese, and Spanish families and the existence of three additional distinct TP53 p.R337H alleles. Mitochondrial DNA sequencing and Y-STR profiling of Brazilian carriers of the founder TP53 p.R337H allele reveal an excess of Native American haplogroups in maternal lineages and exclusively European haplogroups in paternal lineages, consistent with communities established through male European settlers with extensive intermarriage with Indigenous women. The identification of founder and independent TP53 p.R337H alleles underlines the importance for considering the haplotype as a functional unit and the additive effects of constitutive polymorphisms and associated variants in modifier genes that can influence the cancer phenotype.
format Online
Article
Text
id pubmed-10597792
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105977922023-10-26 Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility Pinto, Emilia M. Fridman, Cintia Figueiredo, Bonald C. Salvador, Hector Teixeira, Manuel R. Pinto, Carla Pinheiro, Manuela Kratz, Christian P. Lavarino, Cinzia Legal, Edith A.M. F. Le, Anh Kelly, Gregory Koeppe, Erika Stoffel, Elena M. Breen, Kelsey Hahner, Stefanie Heinze, Britta Techavichit, Piti Krause, Amanda Ogata, Tsutomu Fujisawa, Yasuko Walsh, Michael F. Rana, Huma Q. Maxwell, Kara N. Garber, Judy E. Rodriguez-Galindo, Carlos Ribeiro, Raul C. Zambetti, Gerard P. HGG Adv Article The germline TP53 p.R337H mutation is reported as the most common germline TP53 variant. It exists at a remarkably high frequency in the population of southeast Brazil as founder mutation in two distinct haplotypes with the most frequent co-segregating with the p.E134∗ variant of the XAF1 tumor suppressor and an increased cancer risk. Founder mutations demonstrate linkage disequilibrium with neighboring genetic polymorphic markers that can be used to identify the founder variant in different geographic regions and diverse populations. We report here a shared haplotype among Brazilian, Portuguese, and Spanish families and the existence of three additional distinct TP53 p.R337H alleles. Mitochondrial DNA sequencing and Y-STR profiling of Brazilian carriers of the founder TP53 p.R337H allele reveal an excess of Native American haplogroups in maternal lineages and exclusively European haplogroups in paternal lineages, consistent with communities established through male European settlers with extensive intermarriage with Indigenous women. The identification of founder and independent TP53 p.R337H alleles underlines the importance for considering the haplotype as a functional unit and the additive effects of constitutive polymorphisms and associated variants in modifier genes that can influence the cancer phenotype. Elsevier 2023-10-04 /pmc/articles/PMC10597792/ /pubmed/37794678 http://dx.doi.org/10.1016/j.xhgg.2023.100244 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pinto, Emilia M.
Fridman, Cintia
Figueiredo, Bonald C.
Salvador, Hector
Teixeira, Manuel R.
Pinto, Carla
Pinheiro, Manuela
Kratz, Christian P.
Lavarino, Cinzia
Legal, Edith A.M. F.
Le, Anh
Kelly, Gregory
Koeppe, Erika
Stoffel, Elena M.
Breen, Kelsey
Hahner, Stefanie
Heinze, Britta
Techavichit, Piti
Krause, Amanda
Ogata, Tsutomu
Fujisawa, Yasuko
Walsh, Michael F.
Rana, Huma Q.
Maxwell, Kara N.
Garber, Judy E.
Rodriguez-Galindo, Carlos
Ribeiro, Raul C.
Zambetti, Gerard P.
Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility
title Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility
title_full Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility
title_fullStr Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility
title_full_unstemmed Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility
title_short Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility
title_sort multiple tp53 p.r337h haplotypes and implications for tumor susceptibility
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597792/
https://www.ncbi.nlm.nih.gov/pubmed/37794678
http://dx.doi.org/10.1016/j.xhgg.2023.100244
work_keys_str_mv AT pintoemiliam multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT fridmancintia multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT figueiredobonaldc multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT salvadorhector multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT teixeiramanuelr multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT pintocarla multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT pinheiromanuela multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT kratzchristianp multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT lavarinocinzia multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT legaledithamf multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT leanh multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT kellygregory multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT koeppeerika multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT stoffelelenam multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT breenkelsey multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT hahnerstefanie multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT heinzebritta multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT techavichitpiti multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT krauseamanda multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT ogatatsutomu multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT fujisawayasuko multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT walshmichaelf multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT ranahumaq multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT maxwellkaran multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT garberjudye multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT rodriguezgalindocarlos multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT ribeiroraulc multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility
AT zambettigerardp multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility